Schaeffer P - Search Results

1

5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor.

Meneyrol J, Follmann M, Lassalle G, Wehner V, Barre G, Rousseaux T, Altenburger JM, Petit F, Bocskei Z, Schreuder H, Alet N, Herault JP, Millet L, Dol F, Florian P, Schaeffer P, Sadoun F, Klieber S, Briot C, Bono F, Herbert JM. Meneyrol J, et al. Among authors: schaeffer p. J Med Chem. 2013 Dec 12;56(23):9441-56. doi: 10.1021/jm4005835. Epub 2013 Dec 3. J Med Chem. 2013. PMID: 24175584

2

SSR182289A, a selective and potent orally active thrombin inhibitor.

Altenburger JM, Lassalle GY, Matrougui M, Galtier D, Jetha JC, Bocskei Z, Berry CN, Lunven C, Lorrain J, Herault JP, Schaeffer P, O'Connor SE, Herbert JM. Altenburger JM, et al. Among authors: schaeffer p. Bioorg Med Chem. 2004 Apr 1;12(7):1713-30. doi: 10.1016/j.bmc.2004.01.016. Bioorg Med Chem. 2004. PMID: 15028263

3

Human umbilical vein endothelial cells express high affinity receptors for factor Xa.

Bono F, Herault JP, Avril C, Schaeffer P, Lormeau JC, Herbert JM. Bono F, et al. Among authors: schaeffer p. J Cell Physiol. 1997 Jul;172(1):36-43. doi: 10.1002/(SICI)1097-4652(199707)172:1<36::AID-JCP4>3.0.CO;2-E. J Cell Physiol. 1997. PMID: 9207923

4

Coagulation factor Xa induces endothelium-dependent relaxations in rat aorta.

Schaeffer P, Mares AM, Dol F, Bono F, Herbert JM. Schaeffer P, et al. Circ Res. 1997 Nov;81(5):824-8. doi: 10.1161/01.res.81.5.824. Circ Res. 1997. PMID: 9351456

5

Activation of human vascular endothelial cells by factor Xa: effect of specific inhibitors.

Herault JP, Bono F, Avril C, Schaeffer P, Herbert JM. Herault JP, et al. Among authors: schaeffer p. Biochem Pharmacol. 1999 Mar 15;57(6):603-10. doi: 10.1016/s0006-2952(98)00348-7. Biochem Pharmacol. 1999. PMID: 10037444

6

SR123781A, a synthetic heparin mimetic.

Herbert JM, Hérault JP, Bernat A, Savi P, Schaeffer P, Driguez PA, Duchaussoy P, Petitou M. Herbert JM, et al. Among authors: schaeffer p. Thromb Haemost. 2001 May;85(5):852-60. Thromb Haemost. 2001. PMID: 11372679

7

Pharmacokinetics of new synthetic heparin mimetics.

Hérault JP, Bernat A, Roye F, Michaux C, Schaeffer P, Bono F, Petitou M, Herbert JM. Hérault JP, et al. Among authors: schaeffer p. Thromb Haemost. 2002 Jun;87(6):985-9. Thromb Haemost. 2002. PMID: 12083506

8

Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot-bound thrombin and factor Xa in vitro and in vivo.

Hérault JP, Cappelle M, Bernat A, Millet L, Bono F, Schaeffer P, Herbert JM. Hérault JP, et al. Among authors: schaeffer p. J Thromb Haemost. 2003 Sep;1(9):1959-65. doi: 10.1046/j.1538-7836.2003.00358.x. J Thromb Haemost. 2003. PMID: 12941037 Free article.

9

Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy.

Savi P, Herault JP, Duchaussoy P, Millet L, Schaeffer P, Petitou M, Bono F, Herbert JM. Savi P, et al. Among authors: schaeffer p. J Thromb Haemost. 2008 Oct;6(10):1697-706. doi: 10.1111/j.1538-7836.2008.03089.x. Epub 2008 Jul 19. J Thromb Haemost. 2008. PMID: 18647228 Free article.

10

SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.

Alam A, Blanc I, Gueguen-Dorbes G, Duclos O, Bonnin J, Barron P, Laplace MC, Morin G, Gaujarengues F, Dol F, Hérault JP, Schaeffer P, Savi P, Bono F. Alam A, et al. Among authors: schaeffer p. Mol Cancer Ther. 2012 Aug;11(8):1637-49. doi: 10.1158/1535-7163.MCT-11-0866-T. Epub 2012 May 14. Mol Cancer Ther. 2012. PMID: 22584122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

277 results

Search Page